We have previously reported similar findings in an Alzheimer’s disease mouse model, where 11C-DED and GFAP follow divergent trajectories with a later detection of GFAP expression relatively to the detection of high 11C-DED binding [13]. Here, GFAP is linked to Alzheimer disease.